Substrate Fragmentation for the Design of M.tuberculosis CYP121 Inhibitors

Spirooxindoles as novel 3D-fragment scaffolds: Synthesis and screening against CYP121 from M. tuberculosis

Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.

CHAPTER 8 Fragment-Based Discovery of Antibacterials

ChemInform Abstract: Regioselective Conversion of Arenes to N‐Aryl‐1,2,3‐triazoles Using C—H Borylation.

Understanding “On-Water” Catalysis of Organic Reactions. Effects of H⁺ and Li⁺ Ions in the Aqueous Phase and Nonreacting Competitor H-Bond Acceptors in the Organic Phase: On H₂O versus on D₂O for Huisgen Cycloadditions

Natural product-inspired fragment-based drug discovery: Development of M. tuberculosis CYP121 inhibitors

Fragment-based drug discovery of potent and selective CYP121 inhibitors for tuberculosis

Small-Molecule Inhibitors That Target Protein-Protein Interactions in the RAD51 Family of Recombinases

Regioselective conversion of arenes to N-aryl-1,2,3-triazoles Using C-H Borylation